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Differential Plasmodium falciparum 
surface antigen expression among 
children with Malarial Retinopathy
Abdirahman I. Abdi1,2, Symon M Kariuki1, Michelle K. Muthui1, Cheryl A. Kivisi1, 
Gregory Fegan1,3, Evelyn Gitau1,5, Charles R Newton1,4 & Peter C. Bull1,3,†
Retinopathy provides a window into the underlying pathology of life-threatening malarial coma 
(“cerebral malaria”), allowing differentiation between 1) coma caused by sequestration of Plasmodium 
falciparum-infected erythrocytes in the brain and 2) coma with other underlying causes. Parasite 
sequestration in the brain is mediated by PfEMP1; a diverse parasite antigen that is inserted into the 
surface of infected erythrocytes and adheres to various host receptors. PfEMP1 sub-groups called 
“DC8” and “DC13” have been proposed to cause brain pathology through interactions with endothelial 
protein C receptor. To test this we profiled PfEMP1 gene expression in parasites from children with 
clinically defined cerebral malaria, who either had or did not have accompanying retinopathy. We 
found no evidence for an elevation of DC8 or DC13 PfEMP1 expression in children with retinopathy. 
However, the proportional expression of a broad subgroup of PfEMP1 called “group A” was elevated 
in retinopathy patients suggesting that these variants may play a role in the pathology of cerebral 
malaria. Interventions targeting group A PfEMP1 may be effective at reducing brain pathology.
In children living in sub-Saharan Africa, severe malaria presents in three overlapping syndromes (severe malaria 
with impaired consciousness, severe malarial anemia, and severe malaria with respiratory distress)1. Severely 
impaired consciousness or deep coma associated with malaria is referred to as cerebral malaria (CM) and in early 
studies was shown to be associated with accumulation of parasite-infected erythrocytes (IE) in the cerebral blood 
vessels2–4.
Autopsy studies of fatal malaria show large numbers of erythrocytes containing mature stages of P. falciparum 
adhering to the endothelia of the brain microvasculature2–4, obstructing blood flow. In fatal instances of coma 
in children with malaria parasitaemia, the percentage of capillaries containing sequestered malaria parasites can 
differentiate children who died from malaria from those who died of non-malarial causes but happened to carry 
parasites4. The challenge has been to find markers of parasite sequestration in the brain in non-fatal cases of severe 
malaria. Malaria retinopathy has been of great interest in this regard. Malaria retinopathy, characterised by retinal 
whitening, vessel color changes and retinal hemorrhages5,6 has been found to be a surrogate marker of parasite 
sequestration in the brain4 and is the most specific clinical indicator of cerebral sequestration7,8,6.
Sequestration occurs as a result of interaction between IE surface ligands and receptors on the endothelial cells 
that make up the inner wall of the microvasculature (reviewed in9). P. falciparum erythrocyte membrane protein 
one (PfEMP1), is a diverse family of parasite proteins that are inserted into the surface of the IE. These molecules 
play a central role in cytoadhesion of IE to the endothelia of the microcirculation10. Each molecule contains a 
number of functional cytoadhesive domains, with different broad classes of domains having different cytoadhesive 
functions to various host molecules such as ICAM1, CD36, complement receptor 111 and endothelial protein C 
receptor12. PfEMP1 is encoded by a diverse family of about 60 var genes per parasite genome13. These genes can be 
classified based on their upstream 5′ un-translated region (5′ UTR) into different functional groups A, B, C and 
E14. An alternative classification based on combinations of cytoadhesive domains called domain cassettes (DC) has 
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recently been described15. Switching between var genes modifies the antigenic and binding properties of IEs16, and is 
likely to play a role in the distribution of parasites throughout the body. DC8- and DC13-containing PfEMP1 were 
recently selected on human endothelial cells17,18 and transcript levels obtained with primers designed to detect these 
PfEMP1 subtypes were found associated with severe malaria19. These subsets of var genes have been proposed to 
express PfEMP1 with specificity to endothelial protein C receptor (EPCR)12. These studies suggested a mechanism 
for the pathology of cerebral malaria in which binding of parasites to EPCR drives inflammation and endothelial 
activation12,20. As malarial retinopathy is considered a surrogate external marker for IE sequestration in the brain, 
the PfEMP1 subsets associated with strong binding to endothelial cells are expected to play a role in retinopathy. 
We therefore explored the relationship between the expression of various var subsets and malaria retinopathy as a 
way of dissecting the relationship between parasite sequestration in the brain and disease pathology.
Results
Clinical characteristics of patients. The clinical features of the children included in this study were 
described in Table 1. Of the 140 children in the previous study21, who fulfilled the WHO definition of cerebral 
malaria22 and had retinopathy status examined, 80 had available stored RNA samples for var expression analysis. 
Retinopathy was positive (CM-R+) in 25/80(31.25%), and negative (CM-R–) in 55/80 (68.75%), which is similar 
to the original study21, suggesting good representation of the original sample.
For five of the samples, PCR amplification of the reference genes could not be achieved and therefore samples 
from 75 children were analyzed for var expression, of which 52 (69.33%) were CM-R– and 23 (30.66%) were 
CM-R+. Table 1 shows the clinical characteristics of these 75 children. Children with coma co-presenting with 
respiratory distress (RD) tended to be more common among the CM-R- group, though this was not statistically 
significant (p = 0.08, Table 1). Consistent with previous studies23–25 the CM-R+ children tended to be more anemic 
with lower hematocrit, hemoglobin and erythrocyte counts (hct; z = 3.0 p = 003, hb; z = 3.0 p = 003, RBC count; 
z = 3.4, p = 0.0006, Table 1). Elevated plasma PfHRP2 concentration was also associated with the CM-R+ group 
(z =  − 2.2, p = 0.03 Mann-Whitney U test, Table 1) as observed previously25. However, for two markers of endothe-
lial activation (angiopoietin-2 and soluble ICAM-1) previously associated with retinopathy24 the difference between 
the two groups was not significant (Table 1).
Retinopathy is associated with a higher proportion of group A transcript but lower overall var 
transcript quantity. We compared the expression of var genes in parasites isolated from children clinically 
diagnosed with CM-R+ and CM-R- by quantifying the expression of various var gene subsets in parasites from the 
two groups of children using the primers listed in Table S1.
First, as shown in Fig. 1 and Fig. S1, the transcript levels obtained with group A primers including DC13 showed 
no difference between CM-R– and CM-R+ groups (Fig. 1a,b, Fig. S1a,b). In contrast the primers b1 and c2 target-
ing general group B and C var genes respectively showed higher transcript in the CM-R– group (p = 0.002 and 
p < 0.0001 respectively, Fig. 1d,e). Contrary to our expectations, the median transcript quantity of the four DC8 
targeting primers was not significantly different but tended to be higher in the CM-R- group (p = 0.05, Fig. 1c). 
The var subset targeted by the primer dc8-4, detected significantly higher levels of transcript in the CM-R– group 
(p = 0.02, Fig. S1f). Pfsir2a which is an enzyme linked to a role in epigenetic silencing/relaxing of var gene expres-
sion26,27 was also associated with the CM-R– (p = 0.001) but not Pfsir2b (Fig. 1f,g).
The proportion of children with cerebral malaria accompanied by respiratory distress (RD) was higher in the 
CM-R– group (Table 1). This raised the possibility that some var subsets might be differentially associated with RD 
explaining the tendency of parasites from the CM-R- group to express elevated var transcript. If this were the case, 
we would expect a positive association between the expressions of some var subsets and RD. However, in multiple 
logistic regression analysis, none of the var subsets analyzed showed significant positive associations with RD 
N Retinopathy (+)(N = 23) Retinopathy (–)(N = 52) p
age (months) 72 38 (28–57) 46(31–67) 0.4§
Male Sex 72 12/22(54.55) 24/50 (48.0) 0.6¶
Respiratory distress 72 2/22 (9.09) 14/50(28) 0.08¶
Ax temp (°C) 75 37.8 (37.1–38.8) 38.5 (37.45–39.25) 0.15§
Hematocrit (%) 72 17.2(13.3–23.9) 25.6 (22.2–30.9) 0.003§
Hb (grams/dl) 72 6(4.5–8) 8.3(7.2–9.8) 0.003§
RBC x 106/μ l of blood 73 2.6(1.8–3.4) 3.6(3–4.2) 0.0006§
Platelet count 75 91(54–140) 117(50–219) 0.36§
Acidosis (%) 67 11/19(57.89) 26/48(54.17) 0.8¶
PfHRP2 65 28259(13861–34379) 16731 (1984–25467) 0.03§
Peripheral Parasitemia 73 128000(12288–588800) 133400(33078–432000) 0.84§
Angiopoietin-2 (pg/ml) 73 4326.0(3362.1–5123.8) 3649.6(2736.8–5714.2) 0.6§
sICAM-1 (ng/ml) 73 550.3(446.9–648.5) 484.2(407.2–679.4) 0.6§
Died (%) 75 6/23(26.09) 9/52(17.31) 0.4¶
Table 1.  Clinical characteristics of the children. Shown are the median and interquartile range or 
proportions. p-value calculated using either Mann-Whitney U test (§) or chi square test (¶). Acidosis defined as 
base excess ≤ −0.8
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(Fig. S1h) suggesting that the observed negative association between the transcript quantity of some var subsets 
and retinopathy is independent of RD.
The var transcript quantity used in the above analysis was calculated relative to the average expression of two 
reference metabolic genes, and does not provide information on the overall composition of the population of 
parasites causing infection. We therefore calculated the expression of each of the var gene subsets as proportion 
of total measured var transcript and explored the associations of these “proportional expression” values with 
retinopathy. Of the var subsets analyzed, proportional expression of group A var genes was positively associated 
with CM-R+ (p = 0.0009, Fig. 2a) while proportional expression of group B and C were negatively associated with 
CM-R+ (p = 0.05 & p = 0.009 respectively, Fig. 2d,e). Contrary to expectation, proportional expression of DC8 
var genes was negatively associated with CM-R+ (p = 0.03, Fig. 2c) and proportional expression of DC13 var genes 
showed no difference between the two groups (Fig. 2b).
Proportional expression analysis by qPCR has limitations because different defined subgroups of var genes 
frequently carry shared sequence features meaning that various primer sets used to quantify var gene expression 
can amplify overlapping sets of genes. We performed secondary analyses to explore the potential impact of this 
Figure 1. var transcript quantity and retinopathy. Dot plots showing the transcript quantity of different var 
subsets and Pfsir2 in parasites from children with cerebral malaria either without or with retinopathy (CM-R– 
and CM-R+). Each dot represents a single isolate. GroupA_median = is the median transcript quantity obtained 
with primers gpA1 and gpA2 (Table S1). DC8_median is the median transcript quantity obtained with the 
four-dc8 targeting primers. Group B and C represent the transcript quantity obtained with the primers b1 and 
c2 (Table S1). The red horizontal bar is the overall median. Significance of difference between CM-R– and CM-
R+ are indicated as p values calculated using the Mann-whitney U test.
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overlap on our analysis. Previous data suggests that the gpA2 primer tends to amplify some DC8 transcript and 
dc8-3 primer has limited specificity19. In the secondary analysis we therefore used gpA1 primers alone to represent 
group A and excluded dc8-3 in the calculation of DC8 median transcript. We then re-calculated the proportional 
expression of the var subgroups and tested their associations with retinopathy. Consistent with the primary analysis 
shown in Fig. 2, proportional expression of group A (gpA1) was positively associated with retinopathy (p = 0.02, 
Fig. S2a) while group B(b1) and C(c2) were negatively associated with retinopathy (p = 0.03, p = 0.009 respectively, 
Figure 2. var transcript proportional expression and retinopathy. (a–e) are dot plots showing the 
proportional expression of broad classes of var genes in relation to retinopathy status. Each dot represents a 
parasite isolate from a child. Group A and DC8 proportional expression represented the proportions of the total 
measured var transcript contributed by groupA_median and DC8_median. GroupA median and DC8_median 
are defined in Fig.1 above but calculated in this case as Tus = 2(5-∆ct). (f) Shows a plot of odds ratio and 95%CI 
of logistic regression models predicting retinopathy. Shown on the left is the association between Group A 
proportional expression and retinopathy with and without adjusting for admission hemoglobin level. Also 
shown (on the right) is the association between admission hemoglobin and retinopathy with and without 
adjusting for group A proportional expression.
www.nature.com/scientificreports/
5Scientific RepoRts | 5:18034 | DOI: 10.1038/srep18034
Fig. S2d,e). Proportional expression of DC8 and DC13 showed no difference between the two groups (p = 0.5, 
p = 0.9 respectively, Fig. S2b-c).
Finally, to estimate proportional expression of non-overlapping var groups (A, B and C), we excluded transcript 
contributed by DC8, DC13 and gpA2 primers from the analysis. With this approach group A (gpA1) proportional 
expression remains positively associated with CM-R+ (p = 0.01, Fig. S3a) while group B and C proportional tran-
script remained negatively associated with CM-R+ (p = 0.03, p = 0.01 respectively, Fig. S3b,c).
In previous studies parasites expressing higher proportion of group A-like var genes was associated with both 
clinically defined cerebral malaria and severe malaria anemia28. Since children with retinopathy tended to be 
anemic (Table 1), we used logistic regression to test whether the association between retinopathy and group 
A proportional expression is explained by the different levels of anemia. We first used each of them as the only 
explanatory variable in a logistic regression model predicting retinopathy, then in combination to adjust for one 
another. As shown in Fig. 2f, despite a slight reduction in the odd ratio when adjusted for admission hemoglobin, 
the group A proportional transcript remained significantly associated with retinopathy (OR(95%CI): unadjusted; 
(73.97(2.8,1942.0), p = 0.01 adjusted; (42.21(1.41,1267.30), p = 0.03). Similarly admission hemoglobin remained 
significantly associated with retinopathy when adjusted for group A proportional transcript (OR (95%CI): unad-
justed; 0.72(0.56, 0.91), p = 0.006, adjusted; (0.76(0.59,0.97), p = 0.03). This result suggests the association between 
group A and retinopathy is independent of anemia.
var transcript quantity is associated with Pfsir2 expression. A recent work on P. falciparum isolates 
from Gambian Children suggested PfSIR2 involvement in deregulation of var gene expression especially those of 
group B and in the pathogenesis of severe malaria29. Surprisingly, there was evidence for elevated PfSIR2 in the 
retinopathy negative group when compared to the retinopathy positive group. PfSir2a was significantly higher in 
Figure 3. Correlation matrix and Principal factor analysis. (a) A correlation matrix: Shown are Spearman’s 
correlation coefficients of the associations between the variables (N = 62). The background shading is based on 
the p value of the associations. The darker the background colors the smaller the p value ; dark red = p < 0.0005, 
mid red = p < 0.005 - ≥ 0.0005, light red = p < 0.05 - ≥ 0.005. mid blue = p < 0.005 - ≥ 0.0005, light blue = p < 0.05 
- ≥ 0.005. Red background indicates positive associations and blue background indicate negative associations. 
(b) The relationship between factor scores derived from principal factor analysis and retinopathy: A plot of 
odds ratio and 95% CI of three logistic regression models predicting retinopathy using either factor 1 factor 2 or 
factor 3 scores as sole explanatory variables. More details of these factors are shown in Table 2.
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the retinopathy negative group (Fig. 1f). However, Consistent with Merrick et al.29. Pfsir2 expression, particularly 
Pfsir2a, was positively associated with the transcript quantity determined with primers gpA1, dc8-3, b1 and c2 
(Fig. 3A) but the strongest association was observed with group B (b1) and C (c2) var genes (Fig. 3a: b1; rho = 0.65, 
p < 0.0001, c2; rho = 0.48, p = 0.0001, Spearman’s rank correlation coefficient). We also observed a positive rela-
tionship between Pfsir2 and body temperature (Fig. 3a; p = 0.02 for both, Pfsir2a, and Pfsir2b). However, of these 
associations, only Pfsir2a association with b1 (adjusted p < 0.0001) and c2 (adjusted p = 0.01) and Pfsir2b with b1 
(adjusted p = 0006) remained significant after bonferroni corrections for multiple comparisons.
Plasma ang-2 associated with PfHRP2. DC8, DC13, and various group A PfEMP1s have been shown 
to bind vascular endothelial cells through endothelial protein C receptor (EPCR)12,30. This interaction has been 
hypothesized to lead to inflammation and endothelial activation12,20. However, as shown above, despite the proposal 
that retinopathy acts as a window into broader brain pathology, we did not find evidence for a positive association 
between retinopathy and DC8 or DC13 expression (Figs 1 and 2). We therefore tested the relationship between a 
marker of widespread endothelial activation (ang-2) and expression of the various var subsets including DC8 and 
DC13. None of the var subsets showed association with ang-2 (Fig. 3a). Instead ang-2 was positively associated with 
PfHRP2 and sICAM-1 (Fig. 3a). Ang-2 was also negatively associated with admission hematocrit, hemoglobin, 
and RBC count (Fig. 3a). When bonferroni adjusted for multiple comparisons, only the association between ang-2 
and sICAM-1 remained significant (p = 0.002).
Principal factor analysis. To gain a greater understanding of the pattern of correlation among the variables 
and to identify clusters of variables that are more closely correlated, we used principal factor analysis. As shown in 
Table 2, the variables clustered into 3 major factors labeled factor 1, factor 2 and factor 3. Factor 1 explains 55.65% 
of the variation, and is significantly associated with estimated expression quantity of group A (gpA1, gpA2,) and 
DC8 (dc8-1, dc8-2, dc8-3, dc8-4). Factor2 that explains 22.57% of the variations is positively associated with esti-
mated expression quantity of group B (b1) and C (c2) var genes, Pfsir2a, and Pfsir2b, and axillary temperature. 
PfHRP2, sICAM-1, ang-2, and 1/hematocrit was positively associated with factor 3, which explains 14% of the 
variation (Table 2).
To further explore the result of the factor analysis, we used the predicted factor scores as explanatory variables 
predicting retinopathy. As shown in Fig. 3b, both factor 1 and factor 2 showed negative associations with retinop-
athy (OR (95%CI): factor 1; 0.45 (0.23, 0.89) p = 0.02, factor 2; 0.20 (0.08, 0.54) p = 0.004) whereas factor 3 showed 
no association with retinopathy (OR (95%CI) = 1.18 (0.62, 2.27), p = 0.6).
Variables Factor 1 Factor 2 Factor 3 Uniqueness
gpA1 0.64 0.15 0.14 0.43
gpA2 0.79 − 0.04 0.13 0.35
dc13 0.23 0.06 0.04 0.93
dc8-1 0.78 − 0.07 − 0.01 0.45
dc8-2 0.68 − 0.14 − 0.22 0.63
dc8-3 0.85 0.01 − 0.23 0.29
dc8-4 0.36 0.16 0.31 0.66
dc9 0.29 0.29 0.003 0.75
temp 0.13 0.33 0.09 0.82
b1 − 0.01 0.80 0.14 0.36
c2 0.2023 0.57 0.064 0.52
Pfsir2a − 0.06 0.88 − 0.06 0.26
Pfsir2b 0.04 0.53 − 0.02 0.70
1/hct 0.15 −0.48 0.36 0.65
PfHRP2 − 0.06 − 0.24 0.42 0.75
sICAM-1 − 0.1591 0.17 0.76 0.46
Ang-2 0.0561 − 0.09 0.66 0.54
Eigenvalue 4.52 1.83 1.14
proportion 55.65% 22.57% 14%
Table 2. Principal factor analysis. Principal factor analysis with promax rotation: Three major factors 
labeled as factor 1, factor 2 and factor 3 were retained on the basis of eigenvalue > 1. In bold is the associations 
(loadings) between the measured variables and the factors (latent variables) that were considered significant 
(> 0.3 or < − 0.3). Factor1 represent group A and DC8 var gene subsets and it account for 55.65% of the 
variation, factor2 represent group B and C var genes, Pfsir2A and Pfsir2B, and it accounts for 22.57% of the 
variation and factor3 consist of PfHRP2, host hematocrit level, plasma ang-2 and sICAM-1 levels and it 
accounts for 14% of the variation in the data. 1/hct loads positively on factor3 and negatively on factor2. N = 62. 
kmo = 0.77.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:18034 | DOI: 10.1038/srep18034
Discussion
Malarial retinopathy has been shown to be an important clinical marker of in vivo sequestration of malaria parasite 
infected erythrocytes (IE) in the brain7. Because the capillaries in the retina are closely connected to those in the 
brain31, the retina provides a window into the pathophysiology underlying cerebral malaria allowing a distinction to 
be made between children with coma caused by sequestration of parasites and those whose coma has other causes4,7. 
As PfEMP1 is thought to be a major ligand expressed on the IE responsible for sequestration, this study aimed to 
identify PfEMP1 subsets associated with sequestration of IE during retinopathy by comparing the var expression 
profile of parasites from children with cerebral malaria with and without retinopathy (CM-R+ and CM-R–).
Parasites selected for binding on human brain endothelial cells were recently found to express predominantly 
a subset of group B and group A PfEMP1 containing domain cassettes 8 and 13 respectively17,18. These parasites 
were also found to bind several endothelial cell-lines derived from various organs suggesting this subset of PfEMP1 
confer the parasite growth advantage through their strong cytoadhesive properties17,18,32. PfEMP1 containing DC8 
and DC13 have been proposed to bind endothelial cells through protein C receptor (EPCR)12 leading to a loss of 
EPCR20. Because of the role of EPCR in regulating inflammation, this further led to the hypothesis that parasite 
interaction with EPCR may induce inflammation, coagulation and endothelial activation12,20 potentially explaining 
much of the pathology of cerebral malaria.
Given the ability of retinopathy to distinguish between cerebral malaria caused by parasite mediated brain 
pathology and other causes with incidental parasitemia4, one aim of this study was to determine whether we could 
identify an association between these specific subsets of PfEMP1 and retinopathy among children with cerebral 
malaria. However, contrary to our expectation, we found no difference in var transcript quantity that would support 
enrichment in DC8 or DC13 PfEMP1 in children with retinopathy. Overall there was either no difference between 
the two groups or, higher levels in the retinopathy negative (CM-R-) group (Fig. 1 and Fig. S1). The positive asso-
ciations between Group A proportional transcript and retinopathy suggest IE sequestration in the brain during 
cerebral malaria may involve group A mediated cytoadhesion. This is consistent with previous studies that showed 
group A-like var genes expression is associated with cerebral malaria28,33–35. Group A PfEMP1 are generally long 
molecules with large number of domains36. One of the cytoadhesive phenotypes associated with group A PfEMP1 
is rosetting34,37. This involves the adhesion of IE to uninfected erythrocytes. DC13 also carried by a subset of group 
A genes associated with binding to EPCR via their CIDR domains. However non-DC13 group A var genes have 
also been shown to mediate binding to EPCR12. Therefore we cannot exclude the possibility of EPCR binding 
playing an important role through var genes that are not amplified by the primers used to detect DC8 and DC13. 
Overall, our result suggests an involvement of group A PfEMP1 in retinopathy. This PfEMP1 subset could 
potentially support parasite growth through strong cytoadhesive properties consistent with autopsy studies showing 
that cerebral malaria is associated with parasite sequestration in multiple organs38.
We previously examined the association between group A PfEMP1 expression and a marker of widespread 
endothelial activation ang-239. We found that expression of group A-like var genes and plasma ang-2 were inde-
pendently associated with severe malaria suggesting that group A PfEMP1 do not play a direct role in widespread 
endothelial activation39. We further show here that widespread endothelial activation measured through ang-2 
appears not to be the direct result of var genes including DC8 and DC13 (Fig. 3a), since there was no evidence for 
an association. Instead plasma levels of ang-2 were positively associated with PfHRP2 and negatively with admission 
hemoglobin level (Fig. 3a). The factor analysis further illustrates this result (Table 2). Plasma ang-2, sICAM-1 and 
PfHRP2 load on the same factor (Table 2). This result is supported by a recent study that showed microvascular 
obstruction and endothelial activation are independently associated with severe malaria40.
It is important to re-emphasise the fact that the estimated quantity of var gene transcript expressed, as opposed 
to the proportional expression, was generally reduced among children with retinopathy. We speculate that this may 
be the result of congestion. Congestion is defined as excessive accumulation of blood cells in the microcirculation 
as a consequence of both sequestered IE that reduce the lumen of the blood vessel and increased rigidity of host 
erythrocytes31. Congestion is likely to play an important role in the development of malarial retinopathy. In an 
adult study, although congestion and sequestration were found to be highly correlated, congestion was a better 
predictor of coma41. Recently Barrera et al.42 showed that congestion is positively associated with the severity of 
retinopathy supporting involvement of congestion in malarial retinopathy.
Congestion may influence the overall level of PfEMP1 expressed by the infecting parasite population. Parasite 
expresses PfEMP1 on the surface of IE to avoid host splenic clearance43–45. In previous studies in which the spleen 
was removed, increased number of mature parasites in peripheral circulation was observed43–45 and the circulating 
population were found to be unable to cytoadhere43. As the microcirculation gets congested as a result of cytoadhe-
sion of IE and slowed movement of blood due to increased rigidity of erythrocytes induced by prolonged infection, 
sequestration of parasites may occur without necessarily expressing high quantity of PfEMP1. In terms of evasion of 
host antibodies, lowered PfEMP1 expression may give a within-host survival advantage to parasites and might help 
explain the overall lower var gene transcript quantity observed in the parasites from the CM-R+ group. However, 
because we have not directly measured the level of congestion in this study these suggestions are still speculative.
Unlike previous studies, the comparison made in this study is between two groups of children with severe 
malaria who cannot be distinguished through their clinical symptoms. In previous studies var expression compar-
ison was between parasites from children with 1) severe malaria and non-severe malaria19,28,46 or 2) either of the 
severe malaria syndromes (impaired consciousness, respiratory distress, severe malaria anaemia) and non-severe 
malaria19,28, or 3) clinical malaria and asymptomatic infection47. In these studies, elevated expression of group A, 
DC8, or DC13 var genes was observed in severe cases. In a separate manuscript, we have showed that expression 
of DC8 and DC13 expression was higher in parasites from children with severe malaria compared to non-severe 
malaria confirming technical consistency with studies conducted elsewhere.
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Conclusions
In summary our data suggests that retinopathy is associated with higher proportional expression of group A 
var genes but overall lower var gene transcript quantity. We have suggested that, under the condition of reduced 
movement of blood in the microcirculation and congestion, parasites may be able to sequester without making 
the normal level of investment in the expression of PfEMP1.
Materials and Methods
This study is nested in a published study whose objective was to understand the value of malarial retinopathy in 
cerebral malaria21. Participants included children admitted to Kilifi County Hospital (formally known as Kilifi 
District Hospital) between July 2005 and December 2011 with a combination of malaria parasites and coma. This 
means all the children in this study had severe malaria. Retinopathy status was assessed at admission as described 
previously21. In this study we included all those children who were positive for malaria and had a parasite sample 
frozen in TRIzol available for var expression analysis. Plasma PfHRP2 concentration was determined as described 
in Kariuki et al.21. Angiopoietin-2 and soluble ICAM-1 (sICAM-1) plasma levels were determined using commer-
cial ELISA kits DANG20 and DY720 respectively from R&D following manufacturer’s protocol.
Definition of terms. Cerebral malaria was defined as admission with coma (Blantyre coma score≤ 2) and 
presence of P. falciparum malaria on a Giemsa stained blood-slide without presence of another cause of coma such 
as hypoglycemia or meningitis48. Retinopathy was defined as presence of hemorrhages, peripheral whitening, 
macular whitening, vessel color changes, and or papilledema6. Acidosis was defined as a base excess value of ≤ − 8.
Var transcript quantification using quantitative PCR. Patient samples were processed as described 
previously28,34. A subset of previously described primers (Table S1) was used to quantify var genes in qPCR19,46. 
These included four primers targeting DC8 (named dc8-1, dc8-2, dc8-3, dc8-4), one primer for each of DC13 
(dc13) and DC9 (dc9). Two primers targeting the majority of group A var genes (gpA1 and gpA2) were used to 
quantify group A var gene expression (Table S1). In addition, we quantified the expression of group B (b1) and C 
(c2) var genes using primers described in46 (Table S1). Expression of two genes; Pfsir2a and Pfsir2b involved in 
epigenetic control of var gene expression was analysed (Table S1). Two housekeeping genes, Seryl tRNA synthetase 
and Fructose bisphosphate aldolase49 were used for relative quantification of the expressed genes. Amplification 
efficiency of the primers was determined by generation of standard curves over 5 logs (100 ng to 10 pg of IT4 
gDNA). All the primers had above 90% amplification efficiency over this range. For the Real-time qPCR, the PCR 
reaction and cycling conditions were carried out as described in19 with the Applied Biosystems 7500 Real-time PCR 
system. Cycle threshold (Ct) was set at 0.025. Controls with no template were included at the end of each batch of 
22 samples per primer and the melt-curves analysed for non-specific amplification. We used genomic DNA from 
IT4 laboratory parasite line at 10ng/μ l as a standard sample included in all plates because we were able to get suc-
cessful amplification using this line with all the primers used in this study. The ∆∆ct relative quantification method 
was used to calculate the arbitrary transcript unit (Tus) here referred to as “transcript quantity” using the formula 
(Tus = 2(5-∆∆ct)) modified from lavstsen et al.19. When calculating the “proportional expression” of each var subset 
within each sample comparison, we used the formula (Tus = 2(5-∆ct))19. We assigned a zero Tu value if a reaction did 
not result in detectable amplification after 40 cycles of amplification, i.e. the Ct value was undetermined. Samples 
were excluded from the analysis if amplification of either of the two reference genes, i.e. seryl tRNA synthetase 
and fructose biphosphate aldolase could not be achieved.
Statistical analysis. As group A and DC8 var genes were measured with more than one primer, we used the 
median transcript quantity (calculated as Tus = 2(5-∆∆ct)) obtained with the various primers targeting group A or 
DC8 var genes to represent group A and DC8 var gene expressions, denoted as groupA_median and DC8_median 
respectively. That is groupA_median = ((gpA1 + gpA2)/2) and DC8_median = (dc8-1 + dc8-2 + dc8-3 + dc8-
4-min(dc8-1, dc8-2, dc8-3, dc8-4)-max(dc8-1,dc8-2, dc8-3, dc8-4))/2. Since the primer dc8-3 is less specific19, 
we also recalculated DC8_median after excluding dc8-3 as follows; DC8_median_2 = dc8-1 + dc8-2 + dc8-
4-min(dc8-1, dc8-2, dc8-4)-max(dc8-1, dc8-2, dc8-4). To calculate the transcript proportion contributed by 
each of the var subset, we summed the transcript quantity (calculated as Tus = 2(5-∆ct)) of all the var subsets ana-
lysed, i.e. sum var transcript = (groupA_median + dc13 + DC8_median + b1 + c2) or (gpA1 + dc13 + DC8_
median_2 + b1 + c2). We then calculated the proportional contribution by each of the subsets. Mann-Whitney U 
test was used to assess the difference in var expression between retinopathy positive and negative groups.
Logistic regression analysis. To test whether the relationship between proportional expression of group A 
and retinopathy is independent of anemia, we used three logistic regression models each predicting retinopathy 
using either 1) group A proportional transcript, or 2) admission hemoglobin, or 3) both as explanatory variables. 
Malaria retinopathy was a binary variable and was the outcome or dependent variable in all the three logistic 
regression models. Both group A proportional transcript and admission hemoglobin were normally distributed, 
and were entered into the logistic regression models as explanatory or independent variables.
Correlation matrix. Was generated using Spearman’s rank correlation coefficient test. The exact p value was 
determined using the command di ‘r(p)’ in Stata.
Principal factor analysis. In this analysis factors with an Eigenvalue > 1 was considered for further analysis. 
To optimize the factor loadings, we used promax rotation. Loadings > 0.3 or < -0.3 were considered significant. 
We generated predicted factor scores for each individual (using the command “predict” in Stata) and used these 
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generated factor scores as independent variables in a logistic regression analysis with retinopathy as the dependent/
outcome variable.
To have the transcript quantity (Tus values) data normally distributed before use in factor analysis we added 
0.1 to all values (to eliminate zeros) and then log transformed all the resultant Tus values.
All statistical analyses were performed using Stata version 13.
Ethics statement. Ethical approval was obtained from Kenya Medical Research Institute (KEMRI) Ethical 
Review Committee (under SSC 1131 and 1249), and written informed consent was obtained from parents/guard-
ians of the study participants. The study methods were carried out in accordance with the approved guidelines.
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